Sangamo Therapeutics (SGMOQ) Receivables (2009 - 2026)
Sangamo Therapeutics (SGMOQ) recorded Receivables of $873,000 in Q1 2026, up 138.5% from $366,000 a year earlier and up 135.3% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Sangamo Therapeutics reported Receivables of $400,000, down 24.0% from FY2024.
- Annual Receivables has declined for four straight years, with a five-year compound annual growth rate of -40.2% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $526,000 in FY2024 (-43.0%), $923,000 in FY2023 (-75.1%), $3.7 million in FY2022 (-38.5%) and $6.01 million in FY2021 (+15.1%).
- The Q1 2026 figure is the highest quarterly Receivables since Q3 2024.
- On a year-over-year basis, Receivables rose in 1 of the last seven quarters, with an average decline of 27.6%.
- Peak year-over-year performance for Receivables in the last five years was growth of 138.5% in Q1 2026, against a decline of 97.4% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $371,000 (Q4 2025), $523,000 (Q3 2025) and $372,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - | 873,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 873,000.00 |
| Dec 31, 2025 | 371,000.00 |
| Sep 30, 2025 | 523,000.00 |
| Jun 30, 2025 | 372,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Sep 30, 2024 | 20.50 Mn |
| Jun 30, 2024 | 581,000.00 |
| Mar 31, 2024 | 691,000.00 |
| Dec 31, 2023 | 923,000.00 |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 7.03 Mn |
| Dec 31, 2022 | 3.70 Mn |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 6.01 Mn |
| Sep 30, 2021 | 7.97 Mn |
| Jun 30, 2021 | 6.88 Mn |
API Access
Sangamo Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();